scholarly article | Q13442814 |
P50 | author | Kenneth W Nickerson | Q101047443 |
P2093 | author name string | Jacob M Hornby | |
Navasona Krishnan | |||
Gerald E Duhamel | |||
Dhammika H M L P Navarathna | |||
Anne Parkhurst | |||
P2860 | cites work | The LPP1 and DPP1 gene products account for most of the isoprenoid phosphate phosphatase activities in Saccharomyces cerevisiae | Q27934767 |
Isolation and characterization of the Saccharomyces cerevisiae DPP1 gene encoding diacylglycerol pyrophosphate phosphatase. | Q27935613 | ||
Nonfilamentous C. albicans mutants are avirulent | Q29617839 | ||
Acquisition, transport, and storage of iron by pathogenic fungi | Q33558328 | ||
Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity | Q33693878 | ||
Regulatory networks controlling Candida albicans morphogenesis | Q33702252 | ||
Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans | Q33859372 | ||
Adherence of Candida albicans and other Candida species to mucosal epithelial cells | Q33899939 | ||
Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis | Q34002848 | ||
Adherence of platelets to Candida species in vivo | Q34003203 | ||
Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice | Q34008664 | ||
Candida albicans-conditioned medium protects yeast cells from oxidative stress: a possible link between quorum sensing and oxidative stress resistance | Q34097610 | ||
Enhanced production of farnesol by Candida albicans treated with four azoles | Q34142059 | ||
Virulence genes in the pathogenic yeast Candida albicans | Q34183709 | ||
Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. | Q35102502 | ||
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis | Q35215948 | ||
Purification and characterization of an autoregulatory substance capable of regulating the morphological transition in Candida albicans | Q35289673 | ||
Alternative Candida albicans lifestyles: growth on surfaces | Q36253562 | ||
Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection | Q36370514 | ||
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus | Q36482511 | ||
Quorum sensing in dimorphic fungi: farnesol and beyond | Q36496583 | ||
Roles of metallic ions in host-parasite interactions | Q37195362 | ||
Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. | Q39491534 | ||
Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule | Q39661623 | ||
Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans | Q39758862 | ||
Isolation and characterization of the Saccharomyces cerevisiae LPP1 gene encoding a Mg2+-independent phosphatidate phosphatase. | Q42060536 | ||
Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection | Q42547262 | ||
Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans | Q42683173 | ||
Evidence for a correlation between proteinase secretion and vulvovaginal candidosis | Q43868803 | ||
Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs | Q44572465 | ||
A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts | Q44836869 | ||
Biologically active fluorescent farnesol analogs | Q46564016 | ||
Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host | Q46611821 | ||
Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis | Q46765883 | ||
Virulence and hyphal formation of Candida albicans require the Ste20p-like protein kinase CaCla4p | Q48046730 | ||
Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog | Q48077116 | ||
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans | Q48168925 | ||
High-frequency switching in Candida albicans and its relations to vaginal candidiasis. | Q54386066 | ||
Predominant pathogens in hospital infections | Q54680963 | ||
The secreted aspartate proteinase of Candida albicans: physiology of secretion and virulence of a proteinase-deficient mutant | Q68540124 | ||
Farnesol, psychosedative and spasmolytic drug | Q68772075 | ||
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol | Q73182577 | ||
Reduction of inorganic substances by yeasts. I. Extracellular reduction of sulfite by species of Candida | Q73206023 | ||
In vitro synergistic effect of farnesol and human gingival cells against Candida albicans | Q79918718 | ||
Iron-source preference of Staphylococcus aureus infections | Q80551515 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Candida albicans | Q310443 |
candidiasis | Q273510 | ||
P304 | page(s) | 1609-1618 | |
P577 | publication date | 2007-02-05 | |
P1433 | published in | Infection and Immunity | Q6029193 |
P1476 | title | Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans | |
P478 | volume | 75 |
Q40541740 | A functional link between hyphal maintenance and quorum sensing in Candida albicans |
Q41991036 | Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions |
Q92071832 | Anticandidal Activity of Kalopanaxsaponin A: Effect on Proliferation, Cell Morphology, and Key Virulence Attributes of Candida albicans |
Q34088663 | Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans |
Q41875229 | Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. |
Q34467917 | Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. |
Q39888288 | Arginine-induced germ tube formation in Candida albicans is essential for escape from murine macrophage line RAW 264.7. |
Q34103520 | Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans |
Q35648733 | CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis |
Q58838308 | Candida Urinary Tract Infection: Pathogenesis |
Q34844550 | Candida albicans Czf1 and Efg1 coordinate the response to farnesol during quorum sensing, white-opaque thermal dimorphism, and cell death. |
Q36160477 | Candida albicans ISW2 Regulates Chlamydospore Suspensor Cell Formation and Virulence In Vivo in a Mouse Model of Disseminated Candidiasis |
Q27317563 | Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis |
Q36053516 | Candida albicans Quorum Sensing Molecules Stimulate Mouse Macrophage Migration |
Q36746973 | Candida albicans Tup1 is involved in farnesol-mediated inhibition of filamentous-growth induction |
Q34188778 | Candida albicans heme oxygenase and its product CO contribute to pathogenesis of candidemia and alter systemic chemokine and cytokine expression |
Q33351140 | Candida and invasive candidiasis: back to basics. |
Q39490081 | Candida biofilms and the host: models and new concepts for eradication |
Q37699331 | Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs |
Q37648725 | Cellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans |
Q35915352 | Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades. |
Q51253744 | Deciphering fungal dimorphism: Farnesol's unanswered questions. |
Q92479050 | Effect of Shikonin Against Candida albicans Biofilms |
Q46702429 | Effect of Trans, Trans-Farnesol on Pseudogymnoascus destructans and Several Closely Related Species |
Q36785890 | Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii. |
Q35949651 | Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model |
Q36362359 | Farnesol and cyclic AMP signaling effects on the hypha-to-yeast transition in Candida albicans |
Q35535689 | Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin |
Q39369560 | Farnesol signalling in Candida albicans - more than just communication |
Q36422270 | From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms |
Q92219139 | Fungal Quorum-Sensing Molecules and Inhibitors with Potential Antifungal Activity: A Review |
Q38773057 | Fungal quorum sensing molecules: Role in fungal morphogenesis and pathogenicity |
Q37548161 | Host-pathogen interaction and signaling molecule secretion are modified in the dpp3 knockout mutant of Candida lusitaniae |
Q35152853 | In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms |
Q64120011 | Linking Cellular Morphogenesis with Antifungal Treatment and Susceptibility in Pathogens |
Q39978770 | Lipid signaling in pathogenic fungi |
Q30542941 | MRI confirms loss of blood-brain barrier integrity in a mouse model of disseminated candidiasis |
Q51364123 | Mechanisms of interaction between Candida albicans and Streptococcus mutans: an experimental and mathematical modelling study. |
Q28483683 | MicroRNA regulation of human protease genes essential for influenza virus replication |
Q34189952 | Modulation of morphogenesis in Candida albicans by various small molecules |
Q33379249 | Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans |
Q46573245 | Pravastatin inhibits farnesol production in Candida albicans and improves survival in a mouse model of systemic candidiasis |
Q33369708 | Prokaryote-eukaryote interactions identified by using Caenorhabditis elegans |
Q42763564 | Quorum sensing and Bacterial Pathogenicity: From Molecules to Disease |
Q39155578 | Quorum sensing by farnesol revisited |
Q46352700 | Quorum sensing in Candida albicans: farnesol versus farnesoic acid |
Q37977983 | Quorum sensing in fungi--a review |
Q34358699 | Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production |
Q40113973 | Study of trans-trans farnesol effect on hyphae formation by Yarrowia lipolytica. |
Q38683382 | Systematic review of the in vitro effects of statins on oral and perioral microorganisms |
Q41199859 | The fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunity |
Q39233357 | The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model |
Q58430830 | Transcriptional Response of Candida parapsilosis following Exposure to Farnesol |
Q35879037 | Transcriptional response of Candida parapsilosis following exposure to farnesol |
Q28484600 | Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans |
Q38955918 | Zap1 control of cell-cell signaling in Candida albicans biofilms |